Molecular characterization of pancreatic neuroendocrine tumor tissue: characterization of altered pathways and potential non-invasive biomarkers
RNA-seq (gene expression) · human · 40 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 40 samples: 36 distinct titles, 4 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Transcriptomic profiling of pancreatic neuroendocrine tumors: dysregulation of WNT, MAPK, PI3K, neddylation pathways and potential non-invasive biomarkersPloS one · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE281039_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1181877 and SRA study SRP543093. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 40 sample titles: 36 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8609688 NET1,Tumor,Non-functioning
- GSM8609689 NET10,Tumor,Non-functioning
- GSM8609690 NET11,Tumor,Non-functioning
- GSM8609691 NET13,Tumor,Non-functioning
- GSM8609692 NET14,Tumor,Non-functioning
- GSM8609693 NET17,Tumor,Non-functioning
- GSM8609694 NET19,Tumor,Non-functioning
- GSM8609695 NET2,Tumor,Non-functioning
- GSM8609696 NET20,Tumor,Non-functioning
- GSM8609697 NET21,Tumor,Non-functioning
- GSM8609698 NET22,Tumor,Non-functioning, NET22_3
- GSM8609699 NET22,Tumor,Non-functioning, NET22_4
- GSM8609700 NET23,Tumor,Non-functioning
- GSM8609701 NET24,Tumor,Non-functioning
- GSM8609702 NET25,Tumor,Non-functioning
- GSM8609703 NET26,Tumor,Non-functioning
- GSM8609704 NET7,Tumor,Non-functioning
- GSM8609705 NET12,Tumor,Non-functioning
- GSM8609706 NET15,Tumor,Non-functioning
- GSM8609707 NET16,Tumor,Non-functioning
- GSM8609708 NET18,Tumor,Non-functioning
- GSM8609709 NET27,Tumor,Non-functioning
- GSM8609710 NET3,Tumor,Non-functioning, NET3_77
- GSM8609711 NET3,Tumor,Non-functioning, NET3_78
- GSM8609712 NET4,Tumor,Non-functioning
- GSM8609713 NET5,Tumor,Non-functioning, NET5_13
- GSM8609714 NET5,Tumor,Non-functioning, NET5_14
- GSM8609715 NET6,Tumor,Non-functioning
- GSM8609716 NET8,Tumor,Non-functioning
- GSM8609717 NET9,Tumor,Non-functioning
- GSM8609718 NET1,Non-tumor,Tumor adjacent pancreatic tissue
- GSM8609719 NET2,Non-tumor,Tumor adjacent pancreatic tissue
- GSM8609720 NET3,Non-tumor,Tumor adjacent pancreatic tissue, 4NT_79
- GSM8609721 NET3,Non-tumor,Tumor adjacent pancreatic tissue, 4NT_80
- GSM8609722 NET61,Non-tumor,Tumor adjacent pancreatic tissue
- GSM8609723 NET4,Non-tumor,Tumor adjacent pancreatic tissue
- GSM8609724 NET28,Non-tumor,Tumor adjacent pancreatic tissue
- GSM8609725 NET29,Tumor,Insulinoma
- GSM8609726 NET30,Tumor,Insulinoma
- GSM8609727 NET28,Tumor,Insulinoma
- GSE293843 Targeting the ferritinophagy-lysosome axis as a therapeutic vulnerability in gastroenteropancreatic neuroendocrine tumors [RNA-Seq] 10 samples shares neuroendocrine, pancreatic
- GSE308390 Identifying Potential Biomarkers Associated with Sebum Production, Pore Enlargement, and Comedones Using Transcriptomic Approaches 24 samples shares biomarkers, potential
- GSE181537 RNA-Seq profiling of circular RNAs in human colorectal cancer 5-fluorouracil resistance and the potential biomarkers 12 samples shares biomarkers, potential
- GSE205154 Bulk RNA-Seq gene expression data for 289 primary and metastatic pancreatic ductal adenocarcinoma (PDAC) tumor samples from FFPE blocks. 289 samples shares pancreatic
- GSE310388 In situ multi-modal characterization of pancreatic cancer reveals tumor cell identity as a defining factor of the surrounding microenvironment. [RNA-Seq] 171 samples shares pancreatic
- GSE319951 Effect of pancreatic tumor interstitial fluid media on transcriptional responses in PDAC cells 54 samples shares pancreatic
- GSE311200 Comprehensive analysis of the correlation between circulating biomarkers and tumor-immune microenvironment in advanced or recurrence non-small cell lung cancer in various treatment options, i.e., immunotherapy, EGFR TKI, and chemotherapy 41 samples shares biomarkers
- GSE279475 Single-Cell RNA-seq analysis of small intestine neuroendocrine tumors reveals the cell of origin and trajectory of gene-expression associated with the early tumor development 34 samples shares neuroendocrine
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.